Industry News

Curated for Orthogate.org Members

EXECUTIVE SUMMARY

• Total Joint Orthopedics Secures Growth Financing to Accelerate Commercial Expansion: Reported by OrthoSpineNews, Total Joint Orthopedics, Inc. secured up to $11 million in debt growth financing through Wells Fargo to accelerate commercial distribution of its Efficiency by Design joint arthroplasty platforms and advance next-generation porous and revision designs for its titanium nitride Aurum technology.
• 3D-Printed Titanium and Zinc Honeycomb Lattice Creates Degradable Orthopaedic Implant: Reported by BONEZONE, an international research team led by Professor K.G. Prashanth at Tallinn University of Technology developed a bioinspired titanium-zinc honeycomb lattice biomaterial combining 3D-printed titanium scaffold mechanics with degradable spark plasma-sintered zinc to reduce stress-shielding while supporting tissue ingrowth and gradual bioresorption.
• Constitution Surgery Alliance Expands into Michigan Through ASC Partnerships: Reported by OrthoSpineNews, Constitution Surgery Alliance announced regional expansion into Michigan via operating partnerships with UnaSource Surgery Center and MiOrtho Surgery Center, expanding outpatient robotic joint arthroplasty and accredited complex spine surgery access across Detroit metropolitan surgical suites.
• Nexus CMF Receives 510(k) Clearance for TruVision Single-Use 1.9mm Arthroscopy System: Nexus CMF, LLC received FDA 510(k) clearance (K260156) for the TruVision Single-Use 1.9mm Arthroscopy System, indicated for diagnostic and operative arthroscopic visualization in extremity joints.
• Centinel Spine Obtains 510(k) Clearance for prodisc C Instrument Line: Centinel Spine, LLC secured FDA 510(k) clearance (K263159) for manual surgical instruments dedicated to site preparation, trial sizing, insertion, and positioning across its prodisc® cervical total disc replacement portfolio.

DAILY ANNOUNCEMENTS BY CATEGORY

Joint Reconstruction

Total Joint Orthopedics, Inc.: Total Joint Orthopedics Secures Growth Financing to Accelerate Commercial Expansion and Product Innovation

• Summary: Total Joint Orthopedics, Inc. (TJO) announced that it has secured a debt growth financing facility of up to $11 million through an expanded banking relationship with Wells Fargo. The capital injection accelerates commercial expansion across hospitals and ambulatory surgery centers (ASCs), supporting increased inventory and specialized instrumentation sets for its Efficiency by Design joint arthroplasty platforms. TJO is deploying funds to advance next-generation porous and revision designs for its Aurum technology, which features a ballistically bonded titanium nitride (TiN) surface engineered to eliminate cobalt chrome, nickel, and chromium sensitizers, as well as developing a next-generation hip stem to complement its Platform Hip System Portfolio.
• Key Details:
  • Device/System Name: Efficiency by Design Platforms, Aurum Technology, and Platform Hip System Portfolio
  • Status: Commercial Growth Financing Closed ($11 Million Debt Facility)
  • Clinical Significance: Expands surgical access to streamlined arthroplasty instrument sets in hospitals and ASCs while eliminating cobalt-chromium sensitizing ions through ballistically bonded titanium nitride surfaces for metal-sensitive total joint replacement candidates.
• Original Source: OrthoSpineNews

Spine & Orthobiologics

Tallinn University of Technology: 3D-Printed Titanium and Zinc Honeycomb Lattice Creates Degradable Orthopaedic Implant

• Summary: An international research team led by Professor K.G. Prashanth at Tallinn University of Technology has developed a hybrid metallic biomaterial architecture combining 3D-printed titanium alloy with degradable zinc. Additive manufacturing was utilized to fabricate a bioinspired hexagonal honeycomb titanium lattice with interconnected pores, which was subsequently infiltrated with pure zinc via spark plasma sintering. The titanium scaffold serves as the permanent load-bearing framework to prevent structural collapse, while the continuous zinc matrix transfers stress, moderates elastic stiffness to reduce stress-shielding, and supports cytocompatibility before gradually absorbing under physiological conditions.
• Key Details:
  • Device/System Name: 3D-Printed Titanium-Zinc Honeycomb Hybrid Biomaterial
  • Status: Preclinical Biomaterial Architecture and Manufacturing Validation Published
  • Clinical Significance: Mitigates the elastic modulus mismatch and stress-shielding inherent to conventional solid metal implants, delivering balanced compressive load support while facilitating tissue ingrowth and gradual bioresorption.
• Original Source: BONEZONE

Trauma & Extremities

Constitution Surgery Alliance: Constitution Surgery Alliance Expands into Michigan Through Partnerships with UnaSource and MiOrtho Surgery Centers

• Summary: Ambulatory surgery center developer and operator Constitution Surgery Alliance (CSA) announced its regional expansion into Michigan via new strategic operating partnerships with UnaSource Surgery Center and MiOrtho Surgery Center in the Detroit metropolitan area. UnaSource is a 5-operating-room facility and one of only 10 ASCs nationally to hold Advanced Orthopedic Certification in total joint replacement and complex spine surgery from the AAAHC. MiOrtho Surgery Center, established in 2021 by Michigan Orthopaedic Surgeons (a 50-physician independent group with 13 locations), operates four state-of-the-art operating suites equipped with advanced robotic joint arthroplasty platforms.
• Key Details:
  • Device/System Name: Orthopaedic ASC Clinical Operations and Robotic Surgical Infrastructure
  • Status: Strategic Regional Operating Partnership and ASC Network Expansion
  • Clinical Significance: Expands outpatient surgical capacity and robotic technology access for complex joint reconstruction and spine procedures within accredited, high-efficiency ambulatory surgical facilities.
• Original Source: OrthoSpineNews

RECENTLY INDEXED FDA 510(k) & PMA CLEARANCES: ORTHOPAEDIC

Note: The openFDA database typically indexes clearances 2 to 4 weeks after the official decision date. Dates shown reflect the FDA decision date, not the indexing date.